CY1113234T1 - Τοπικη ενδορρινικη συνθεση που μπορει να χρησιμοποιηθει στην περιπτωσh ρινικης αποφραξhς - Google Patents

Τοπικη ενδορρινικη συνθεση που μπορει να χρησιμοποιηθει στην περιπτωσh ρινικης αποφραξhς

Info

Publication number
CY1113234T1
CY1113234T1 CY20121100692T CY121100692T CY1113234T1 CY 1113234 T1 CY1113234 T1 CY 1113234T1 CY 20121100692 T CY20121100692 T CY 20121100692T CY 121100692 T CY121100692 T CY 121100692T CY 1113234 T1 CY1113234 T1 CY 1113234T1
Authority
CY
Cyprus
Prior art keywords
composition
case
nose block
local interruption
interruption
Prior art date
Application number
CY20121100692T
Other languages
English (en)
Inventor
Luigi Mercuri
Original Assignee
D.M.G. Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D.M.G. Italia Srl filed Critical D.M.G. Italia Srl
Publication of CY1113234T1 publication Critical patent/CY1113234T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02D—FOUNDATIONS; EXCAVATIONS; EMBANKMENTS; UNDERGROUND OR UNDERWATER STRUCTURES
    • E02D27/00—Foundations as substructures
    • E02D27/01—Flat foundations

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Civil Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Structural Engineering (AREA)
  • Mining & Mineral Resources (AREA)
  • Otolaryngology (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Paleontology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Στο παρόν περιγράφεται μια σύνθεση για τοπική ρινική χρήση που περιέχει καρβοξυμεθυλ-β-γλυκάνη και/ή φωσφογλυκάνη με 18 α- και/ή β-γλυκυρετινικό οξύ, πιθανόν αλατοποιημένο, και λακτοφερίνη που είναι χρήσιμη στην ρινική απόφραξη επίσης με βακτηριδιακές επιπλοκές.
CY20121100692T 2008-08-07 2012-08-03 Τοπικη ενδορρινικη συνθεση που μπορει να χρησιμοποιηθει στην περιπτωσh ρινικης αποφραξhς CY1113234T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2008A000444A IT1391170B1 (it) 2008-08-07 2008-08-07 Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
EP09787835A EP2320870B9 (en) 2008-08-07 2009-08-06 Topical intranasal composition usable in the case of nasal obstruction

Publications (1)

Publication Number Publication Date
CY1113234T1 true CY1113234T1 (el) 2016-04-13

Family

ID=40802139

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100692T CY1113234T1 (el) 2008-08-07 2012-08-03 Τοπικη ενδορρινικη συνθεση που μπορει να χρησιμοποιηθει στην περιπτωσh ρινικης αποφραξhς

Country Status (9)

Country Link
EP (1) EP2320870B9 (el)
AT (1) ATE556701T1 (el)
CY (1) CY1113234T1 (el)
ES (1) ES2384153T3 (el)
IT (1) IT1391170B1 (el)
PL (1) PL2320870T3 (el)
PT (1) PT2320870E (el)
RS (1) RS52425B (el)
WO (1) WO2010016088A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014116903A1 (de) * 2014-08-18 2016-02-18 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineolhaltige Zusammensetzung für die nasale Applikation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291366B1 (it) * 1997-05-14 1999-01-07 Angelini Ricerche Spa Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
US20020054917A1 (en) * 1998-08-14 2002-05-09 Gohlke Marcus B. Compositions comprising beta glucan and lactoferrin, and methods for their use
AU2002365083A1 (en) * 2001-10-17 2003-06-30 Ganado Research, L.L.C. Composition and method to treat viral bacterial and parasitic infections and infestations

Also Published As

Publication number Publication date
ATE556701T1 (de) 2012-05-15
EP2320870A1 (en) 2011-05-18
EP2320870B1 (en) 2012-05-09
WO2010016088A1 (en) 2010-02-11
EP2320870B9 (en) 2013-03-27
RS52425B (en) 2013-02-28
ES2384153T3 (es) 2012-07-02
PL2320870T3 (pl) 2012-10-31
PT2320870E (pt) 2012-06-28
IT1391170B1 (it) 2011-11-18
ITRM20080444A1 (it) 2010-02-08

Similar Documents

Publication Publication Date Title
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
AU2016204344A1 (en) Improved methods and compositions for wound healing
AR076613A1 (es) Alimento para mascotas en forma de alimento granulado recubierto
UY33397A (es) Forma sólida de un naftaleno carboxamida
BRPI0815850A2 (pt) "método para tratar, retardar a progressão, prevenir ou atrasar o desenvolvimento de esquizofrenia em um individuo, composiçã farmaceuticamente aceitável, kit e método para reforçar uma resposta de um individuo a um antipsicótico"
CL2008002042A1 (es) Compuestos derivados de heterociclos nitrogenados enlazados; y su uso en el tratamiento de la diabetes y desordenes metabolicos.
ATE442599T1 (de) Strukturierte orientierte filme zur verwendung in displays
BR112015023425A2 (pt) método e composição para coloração e processamento de uma amostra de urina
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
DE60228235D1 (de) Tiernahrungszusammensetzung zur verbesserung der haut
BR112012016749A2 (pt) "d-aminoácido para uso no tratamento de biofilmes"
MY160041A (en) Compositions and methods for treating parasitic infections
DE602005020639D1 (de) Zusammensetzung aus milchsäure und lactoferrin
MX2011006254A (es) Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa.
BR112015001601A2 (pt) células de levedura tendo curso de tca redutor de piruvato em succinato e superexpressão de uma enzima transidrogenase nad(p)+ exógena
MX2007011493A (es) Modalidades antiinflamatorias.
RS53586B1 (en) DERIVATION OF DECISION
RS54185B1 (en) USE OF 24-ORDER
ATE549022T1 (de) Behandlung von infektionen und deren folgeleiden mit kombinierten dissoziierten glocucorticoid- rezeptor-agonisten und antiinfektionswirkstoffen
MX2009010483A (es) 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas.
ATE431121T1 (de) Folienverband mit applikationshilfe
TW200716577A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
CL2008003602A1 (es) Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.
DE602006018453D1 (de) Filmbildende zusamensetzung
TW200716581A (en) Benzothiazol-2-one derivatives as inhibitors of lipases and phospholipases